Furthermore, de Avila et al. reported that, in patients with hepatitis C virus infection, BDNF was negatively correlated with SF-36 physical functioning [42], which is significantly associated with the activity domain of the CLDQ-NAFLD/NASH [8]. Here, BDNF is linked to metabolic dysfunction-associated steatotic liver disease.